Biotech

All Articles

Ionis axes eye illness from aim ats of Roche-partnered possibility after records disappoint

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of re...

Biogen's CEO mentioned no unsafe handle 2023. He prepares to become bold

.While Biogen's pharma peers are actually hunting for late-stage resources with little bit of danger...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Bio has actually been actually a biotech seeking a pipeline after it junked its own lead ass...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned liberties to a very early Alzheimer's illness plan to Denali Rehabs, g...

Takeda taps new mind people oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Vertex, hammered through AATD once more, drops 2 properties on throw out stack

.Tip's effort to handle a rare genetic health condition has actually reached yet another setback. Th...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of workers

.Vir Biotechnology's second-quarter incomes record had not been short of huge updates. The provider ...

Galapagos stops briefly CAR-T cell treatment hearing over Parkinsonism scenario

.Galapagos has actually stopped enrollment in a trial of a BCMA-directed CAR-T cell treatment, pumpi...

James Wilson leaving Penn to launch 2 new biotechs

.After greater than 30 years, genetics therapy trendsetter James Wilson M.D., Ph.D., is leaving the ...

3 biotechs make an effort to beat the summer heat energy through shedding personnel

.As biotechs seek to transform a fresh page in August, at the very least 3 business have shed worker...